CARIS MPI, INC.

Class 042: Medical and scientific research and analysis services in the field of molecular biology, namely, analyzing molecular data, identifying patient populations, detecting and characterizing disease, predicting treatment responses, and identifying targets for drug development; Providing online non-downloadable software featuring artificial intelligence for analyzing molecular data, identifying patient populations, detecting and characterizing disease, predicting treatment responses, and identifying targets for drug development

Class 044: Genomic and molecular medical testing services for diagnostic or treatment purposes in the field of cancer; diagnostic services, namely, medical diagnostic testing for cancer and other diseases and disorders; providing collected and analyzed medical information in the field of genetic and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; providing medical data and information to healthcare professionals

Class 044: Medical testing for diagnostic or treatment purposes in the field of cancer

Class 042: Providing a website featuring non-downloadable software using artificial intelligence for the diagnosis, detection, screening, disease monitoring, treatment monitoring and therapy selection in the field of cancer; Medical research, namely, assessment of image, genomic and molecular data using artificial intelligence; Class 044: medical analysis of image, genomic and molecular data using artificial intelligence for the diagnosis, detection, screening, disease monitoring, treatment monitoring and therapy selection in the field of cancer

Class 042: Providing medical research and scientific research information, namely, tumor molecular data and patient outcomes data.

Class 042: Providing a website featuring non-downloadable software using artificial intelligence for the diagnosis, detection, screening, disease monitoring, treatment monitoring and therapy selection in the field of cancer; medical analysis of image, genomic and molecular data using artificial intelligence for the diagnosis, detection, screening, disease monitoring, treatment monitoring and therapy selection in the field of cancer; Class 044: Medical research, namely, assessment of image, genomic and molecular data using artificial intelligence

Class 042: Medical and scientific research in the field of oncology; providing medical and scientific research information in the field of oncology; medical and scientific research, namely, whole genome and whole transcriptome sequencing assays for biomarker detection and analysis in patients with leukemia, lymphoma, myeloma, or other hematologic malignancies; Class 044: Medical testing for diagnostic, prognostic, or treatment purposes; medical testing, namely, providing whole genome and whole transcriptome sequencing assays for biomarker detection in patients with leukemia, lymphoma, myeloma, or other hematologic malignancies

Class 044: diagnostic, prognostic and theranostic analysis using artificial intelligence and machine learning; diagnostic, prognostic and theranostic analysis using artificial intelligence and machine learning of next-generation sequencing ¬and other molecular data in the field of cancer research and treatment; providing medical and scientific research information to researchers, patients and medical professionals in the form of reports in the field of molecular profiling for the characterization, diagnosis, treatment and monitoring of cancer.

Class 044: diagnostic, prognostic and theranostic analysis using artificial intelligence and machine learning; diagnostic, prognostic and theranostic analysis using artificial intelligence and machine learning of next-generation sequencing ¬and other molecular data in the field of cancer research and treatment; providing medical and scientific research information to researchers, patients and medical professionals in the form of reports in the field of molecular profiling for the characterization, diagnosis, treatment and monitoring of cancer.

Class 042: Providing a website featuring non-downloadable software using artificial intelligence for the diagnosis, detection, screening, disease monitoring, treatment monitoring and therapy selection in the field of cancer; medical analysis of image, genomic and molecular data using artificial intelligence for the diagnosis, detection, screening, disease monitoring, treatment monitoring and therapy selection in the field of cancer; Class 044: Medical research, namely, assessment of image, genomic and molecular data using artificial intelligence

Medical analysis of imaging, genomic and molecular data using artificial intelligence; medical testing services, namely, analysis of next generation sequencing data for genomic DNA and RNA transcripts using artificial intelligence; No claim is made to the exclusive right to use GENOMIC LANGUAGE MODEL, apart from the mark as shown.; Medical and scientific research, namely, analysis of imaging, genomic and molecular data using artificial intelligence; medical and scientific research services, namely, analysis of next generation sequencing data for genomic DNA and RNA transcripts using artificial intelligence

Medical analysis of imaging, genomic and molecular data using artificial intelligence; medical testing services, namely, analysis of next generation sequencing data for genomic DNA and RNA transcripts using artificial intelligence; Medical and scientific research, namely, analysis of imaging, genomic and molecular data using artificial intelligence; medical and scientific research services, namely, analysis of next generation sequencing data for genomic DNA and RNA transcripts using artificial intelligence

Medical research, namely, assessment of genomic and molecular data using artificial intelligence; Providing a website featuring non-downloadable software using artificial intelligence for the diagnosis, detection, screening, disease monitoring, treatment monitoring and therapy selection in the field of cancer; medical analysis of genomic and molecular data using artificial intelligence for the diagnosis, detection, screening, disease monitoring, treatment monitoring and therapy selection in the field of cancer

Medical research, namely, assessment of genomic and molecular data using artificial intelligence; Providing a website featuring non-downloadable software using artificial intelligence for the diagnosis, detection, screening, disease monitoring, treatment monitoring and therapy selection in the field of cancer; medical analysis of genomic and molecular data using artificial intelligence for the diagnosis, detection, screening, disease monitoring, treatment monitoring and therapy selection in the field of cancer

Medical testing for diagnostic, prognostic, or treatment purposes; medical testing, namely, whole genome and whole transcriptome sequencing assays for biomarker detection in patients with leukemia, lymphoma, myeloma, or other hematologic malignancies; Medical and scientific research in the field of oncology; providing medical and scientific research information in the field of oncology; medical and scientific research, namely, whole genome and whole transcriptome sequencing assays for biomarker detection ¬and analysis in patients with leukemia, lymphoma, myeloma, or other hematologic malignancies

Promoting collaboration within the scientific, research and medical communities to optimize clinical care and outcomes for cancer patients, identify predictive and prognostic markers to further advance molecular profiling and cancer care, promote clinical trials, generate scientific publications, and generate and document additional medical evidence for the appropriate use and impact of molecular profiling for cancer; Promoting the exchange of information and resources within the scientific research and medical communities to optimize clinical care and outcomes for cancer patients, identify predictive and prognostic markers to further advance molecular profiling and cancer care, promote clinical trials, generate scientific publications, and generate and document additional medical evidence for the appropriate use and impact of molecular profiling for cancer; medical research services in the field of cancer; providing a database of combined clinical-genomic data including clinical outcomes for research; organizing meetings for the purpose of collaborating on cancer research

Promoting collaboration within the scientific, research and medical communities to optimize clinical care and outcomes for cancer patients, identify predictive and prognostic markers to further advance molecular profiling and cancer care, promote clinical trials, generate scientific publications, and generate and document additional medical evidence for the appropriate use and impact of molecular profiling for cancer; Promoting the exchange of information and resources within the scientific research and medical communities to optimize clinical care and outcomes for cancer patients, identify predictive and prognostic markers to further advance molecular profiling and cancer care, promote clinical trials, generate scientific publications, and generate and document additional medical evidence for the appropriate use and impact of molecular profiling for cancer; medical research services in the field of cancer; providing a database of combined clinical-genomic data including clinical outcomes for research; organizing meetings for the purpose of collaborating on cancer research

Providing medical information to patients and medical professionals in the form of reports in the field of molecular profiling for the diagnosis, treatment and monitoring of cancer; providing medical information in the field of cancer based on next-generation sequencing (NGS), including whole exome sequencing (WES), whole transcriptome sequencing (WTS), and whole genome sequencing (WGS); Providing medical and scientific research information to researchers, patients and medical professionals in the form of reports in the field of molecular profiling for the characterization of cancer, genomic and transcriptomic characteristics, tumor microenvironment, and determination of biosignatures using bioinformatics and artificial intelligence; providing medical research information in the field of cancer based on next-generation sequencing (NGS), including whole exome sequencing (WES), whole transcriptome sequencing (WTS), and whole genome sequencing (WGS)

Providing medical information to patients and medical professionals in the form of reports in the field of molecular profiling for the diagnosis, treatment and monitoring of cancer; providing medical information in the field of cancer based on next-generation sequencing (NGS), including whole exome sequencing (WES), whole transcriptome sequencing (WTS), and whole genome sequencing (WGS); Providing medical and scientific research information to researchers, patients and medical professionals in the form of reports in the field of molecular profiling for the characterization of cancer, genomic and transcriptomic characteristics, tumor microenvironment, and determination of biosignatures using bioinformatics and artificial intelligence; providing medical research information in the field of cancer based on next-generation sequencing (NGS), including whole exome sequencing (WES), whole transcriptome sequencing (WTS), and whole genome sequencing (WGS)

Providing medical information to patients and medical professionals in the form of reports in the field of molecular profiling for the diagnosis, treatment and monitoring of cancer; providing medical information in the field of cancer based on next-generation sequencing (NGS), including whole exome sequencing (WES), whole transcriptome sequencing (WTS), and whole genome sequencing (WGS); Providing medical and scientific research information to researchers, patients and medical professionals in the form of reports in the field of molecular profiling for the characterization of cancer, genomic and transcriptomic characteristics, tumor microenvironment, and determination of biosignatures using bioinformatics and artificial intelligence; providing medical research information in the field of cancer based on next-generation sequencing (NGS), including whole exome sequencing (WES), whole transcriptome sequencing (WTS), and whole genome sequencing (WGS)

Medical analysis of genomic and transcriptomic data using artificial intelligence to predict promoter methylation of the MGMT (O6-methylguanine-DNA methyltransferase ) gene and therapeutic response of cancers to related therapies.; Medical research services in the field of cancer treatment; providing medical research information, namely, using artificial intelligence to predict promoter methylation of the MGMT (O6-methylguanine-DNA methyltransferase ) gene and therapeutic response of cancers to related therapies.

medical screening services; medical diagnostic testing, monitoring and reporting services; pathology diagnostic services; prognostic analysis services; theranostic analysis services; Medical and scientific research; medical and scientific research services in the fields of anatomic pathology, molecular profiling, blood-based diagnostics, oncology, genomics, and proteomics; pharmaceutical research and development; genetic and proteomic research studies of specimens; genetic and proteomic research studies of specimens, namely, next-generation sequencing, whole exome sequencing, whole transcriptome sequencing, whole genome sequencing, mass spectrometry, genetic signatures, specific genetic targets, DNA/RNA isolation and western blot analysis, facilitating effective clinical trials, product development, and research using large amounts of biospecimens and associated research and patient data; providing medical and scientific research in the fields of oncology, and molecular profiling, genomics and proteomics; conducting clinical trials; Medical research laboratory services; medical research laboratory services, namely, analysis of individualized patient data to aid physicians in determining diagnostic, therapeutic and prognostic objectives for patients; medical research laboratory services, namely, providing patient reports based on analysis of RNA, DNA and protein to aid physicians in determining diagnosis, including screening and early detection, prognosis, and predicting or monitoring residual disease, recurrence and/or therapeutic response for cancer patients; providing a centralized database in the field of molecular diagnostics to allow oncologists to acquire and share molecular tumor profiling information and clinical outcomes within a collaborative, secured environment, all for treatment and diagnostic purposes

medical screening services; medical diagnostic testing, monitoring and reporting services; pathology diagnostic services; prognostic analysis services; theranostic analysis services; "LIFE SCIENCES"; Medical and scientific research; medical and scientific research services in the fields of anatomic pathology, molecular profiling, blood-based diagnostics, oncology, genomics, and proteomics; pharmaceutical research and development; genetic and proteomic research studies of specimens; genetic and proteomic research studies of specimens, namely, next-generation sequencing, whole exome sequencing, whole transcriptome sequencing, whole genome sequencing, mass spectrometry, genetic signatures, specific genetic targets, DNA/RNA isolation and western blot analysis, facilitating effective clinical trials, product development, and research using large amounts of biospecimens and associated research and patient data; providing medical and scientific research in the fields of oncology, and molecular profiling, genomics and proteomics; conducting clinical trials; Medical research laboratory services; medical research laboratory services, namely, analysis of individualized patient data to aid physicians in determining diagnostic, therapeutic and prognostic objectives for patients; medical research laboratory services, namely, providing patient reports based on analysis of RNA, DNA and protein to aid physicians in determining diagnosis, including screening and early detection, prognosis, and predicting or monitoring residual disease, recurrence and/or therapeutic response for cancer patients; providing a centralized database in the field of molecular diagnostics to allow oncologists to acquire and share molecular tumor profiling information and clinical outcomes within a collaborative, secured environment, all for treatment and diagnostic purposes

Genomic and molecular medical testing services for diagnostic or treatment purposes in the field of cancer; diagnostic services, namely, medical diagnostic testing for cancer and other diseases and disorders; providing collected and analyzed medical information in the field of genetic and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; providing medical data and information to healthcare professionals; TUMOR

Medical screening services in the field of cancer; medical analysis of blood tests for cancer screening using artificial intelligence

Medical screening services in the field of cancer; medical diagnostic testing, monitoring and reporting services in the field of cancer; pathology diagnostic services for medical purposes in the field of cancer; prognostic analysis services for medical purposes; theranostic analysis services for medical purposes; molecular diagnostic services for medical purposes; "CDX"; Medical research, namely, assessment of clinical data; Medical research, namely, assessment of molecular profiling data, clinical data, and outcomes data to better understand cancer and treatment thereof

Medical analysis services relating to the treatment of patients; medical analysis of genomic and molecular data using artificial intelligence to identify tissue of cancer origin

Liquid biopsy testing for cancer cells using predictive markers and signatures directed to exome and transcriptome molecular profiling and biopsy testing assays using circulating nucleic acids sequencing (cNAS) for analysis of Whole Exome (cfDNA) and Whole Transcriptome (cfRNA) genes

Genomic and molecular medical testing services for diagnostic or treatment purposes in the field of cancer; diagnostic services, namely, medical diagnostic testing for cancer and other diseases and disorders; providing collected and analyzed medical information in the field of genetic and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; providing medical data and information to healthcare professionals; "CDX"

Class 044: Genomic and molecular medical testing services for diagnostic or treatment purposes in the field of cancer; diagnostic services, namely, medical diagnostic testing for cancer and other diseases and disorders; providing collected and analyzed medical information in the field of genetic and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; providing medical data and information to healthcare professionals

Medical and scientific research and analysis services in the field of molecular biology, namely, analyzing molecular data with multiphasic clustering to produce novel insights to characterize new patterns that better define disease, identify new drug targets, and unlock multidimensional associations

Medical screening services in the field of cancer; medical diagnostic testing, monitoring and reporting services in the field of cancer; pathology diagnostic services for medical purposes in the field of cancer; prognostic analysis services for medical purposes; theranostic analysis services for medical purposes; molecular diagnostic services for medical purposes; Medical research, namely, assessment of clinical data; Medical research, namely, assessment of molecular profiling data, clinical data, and outcomes data to better understand cancer and treatment thereof

Medical analysis services relating to the treatment of patients, namely, medical analysis of genomic and molecular data for the treatment of cancer

Healthcare and medical services, namely, providing a database in the field of molecular profiling to allow users to acquire, utilize, access, analyze, or share molecular tumor profiling derived information including clinical outcomes within a collaborative, secured environment all for treatment and diagnostic purposes; Research services, namely, providing a database in the field of molecular profiling to allow users to acquire, utilize, access, analyze, or share molecular tumor profiling derived information including clinical outcomes within a collaborative, secured environment all for scientific research and drug development purposes; providing a website featuring non-downloadable software using artificial intelligence for the research and development of cancer treatments and protocols

"FOLFOX AI"

Class 044: Genomic and molecular medical testing services for diagnostic or treatment purposes in the field of cancer; diagnostic services, namely, medical diagnostic testing for cancer and other diseases and disorders; providing collected and analyzed medical information in the field of genetic and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; providing medical data and information to healthcare professionals

Class 044: Medical prognostic analysis services for medical purposes relative to cancer; medical theranostic analysis services in the nature of generating cancer treatment selection reports for others based on tumor molecular profiling, namely, the generation of tumor theranostic profiling reports containing therapies relative to cancer for patients and their physicians

Class 044: Genomic and molecular medical testing for cancer and other diagnostic or treatment purposes; diagnostic services, namely, medical diagnostic testing for cancer and other diseases and disorders; providing collected and analyzed medical information in the field of genetic and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; providing medical data and information to healthcare professionals; molecular medical testing for cancer using comparison of genomic characteristics of test sample with database of known characteristics

Medical screening services in the field of oncology related clinical trials

Medical screening services in the field of oncology related clinical trials

Providing use of non-downloadable software for use in connection with research management services for physicians and patients, namely, research management services for enrolling patients in medical clinical trials; providing use of non-downloadable software for use in connection with patient screening and recruitment services for oncology related clinical trials; providing use of non-downloadable software for use in connection with oncology clinical trial site activation

Class 042: Medical research services, namely, providing medical, genetic, and genomic information and data for scientific, laboratory, and medical research and development purposes; Class 044: Genomic and molecular medical testing services for diagnostic or treatment purposes in the field of cancer; diagnostic services, namely, medical diagnostic testing for cancer and other diseases and disorders; providing collected and analyzed medical information in the field of genetic and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; providing medical data and information to healthcare professionals

Genomic and molecular medical testing services for diagnostic or treatment purposes in the field of cancer; diagnostic services, namely, medical diagnostic testing for cancer and other diseases and disorders; providing collected and analyzed medical information in the field of genetic and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; providing medical data and information to healthcare professionals; "TRANSCRIPTOME"; Medical research services, namely, providing medical, genetic, and genomic information and data for scientific, laboratory, and medical research and development purposes

Providing collected and analyzed medical information in the field of genetic and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; providing medical data and information to healthcare professionals

Class 044: Genomic and molecular medical testing for cancer and other diagnostic or treatment purposes; diagnostic services, namely, medical diagnostic testing for cancer and other diseases and disorders; providing collected and analyzed medical information in the field of genetic and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; providing medical data and information to healthcare professionals

Healthcare and medical services, namely, providing a database in the field of molecular profiling to allow users to acquire, utilize, access, or share molecular tumor profiling derived information including clinical outcome within a collaborative, secured environment all for treatment and diagnostic purposes; Research services, namely, providing a database in the field of molecular profiling to allow users to acquire, utilize, access, or share molecular tumor profiling derived information including clinical outcome within a collaborative, secured environment all for scientific research purposes

"PROFILE"

Class 042: Medical research, namely, assessment of clinical data; Medical research, namely, annotation of individualized clinical data with published clinical data results; Class 044: medical screening services in the field of cancer; medical diagnostic testing, monitoring and reporting services; pathology diagnostic services for medical purposes; prognostic analysis services for medical purposes; theranostic analysis services for medical purposes; molecular diagnostic services for medical purposes

"BIOREPOSITORY"

Class 044: medical screening services; medical diagnostic testing, monitoring and reporting services; pathology diagnostic services; prognostic analysis services; theranostic analysis services

Class 044: medical screening services; medical diagnostic testing, monitoring and reporting services; pathology diagnostic services; prognostic analysis services; theranostic analysis services

Class 044: Medical diagnostic, theranostic, prognostic and analysis services, and pathology diagnostic services

"BREAST"

"BREAST"

"COLON"

"COLON"

Class 044: Medical services, namely, analysis of individualized patient data to aid physicians in determining diagnostic, therapeutic and prognostic objectives for patients

Class 044: Medical services, namely, analysis of individualized patient data to aid physicians in determining diagnostic, therapeutic and prognostic objectives for patients

"LUNG"

"LUNG"

"LYMPHOMA"

"LYMPHOMA"

"KITS"